{"schema_version":"secwatch.filing_event.v1","accession":"0001737287-21-000034","form_type":"8-K","ticker":"ALLO","cik":"0001737287","company_name":"Allogene Therapeutics, Inc.","filed_at":"2021-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.436682+00:00","generated_at":"2026-06-30T00:01:23.721004+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Allogene Therapeutics expands board to 11, appoints Elizabeth Barrett and Vicki Sato as directors","bullets":["Board increased from 9 to 11; Barrett (Class I) and Dr. Sato (Class II) appointed effective July 30, 2021.","Barrett receives annual retainer of $40,000 and option grant with $850,000 grant date value vesting over 3 years.","Dr. Sato receives $40,000 retainer, option grant of $425,000 value (3-year vest), and RSU award of $425,000 value (3 annual installments).","Both directors enter indemnification agreements; equity grants accelerate on change of control."],"urls":{"canonical":"https://secwatch.observer/filing/0001737287-21-000034","json":"https://secwatch.observer/filing/0001737287-21-000034.json","markdown":"https://secwatch.observer/filing/0001737287-21-000034.md","text":"https://secwatch.observer/filing/0001737287-21-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737287/000173728721000034/0001737287-21-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737287/000173728721000034/allo-20210730.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T00:01:23.721004+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"52f710292a","claim":"Elizabeth Barrett was appointed as Class I director at Allogene Therapeutics, Inc..","evidence_excerpt":"appointed Elizabeth Barrett as a Class I director of the Company to fill one of the newly created vacancies, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728721000034/0001737287-21-000034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}